BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Aarti Pharmalabs Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543748
ISIN Demat
INE0LRU01027
Book Value (Rs)
218.6629199
NSE Symbol
AARTIPHARM
Divident Yield %
0.52
Market Cap
(Rs In Cr.)
6,141
P/E (TTM)
34.44
EPS (TTM)
19.67
Face Value
(Rs)
5
Back
Aarti Pharmalabs consolidated net profit declines 30.81% in the March 2026 quarter
26-May-26   Hrs IST

Net profit of Aarti Pharmalabs declined 30.81% to Rs 61.12 crore in the quarter ended March 2026 as against Rs 88.34 crore during the previous quarter ended March 2025. Sales rose 3.35% to Rs 582.64 crore in the quarter ended March 2026 as against Rs 563.78 crore during the previous quarter ended March 2025.

For the full year,net profit declined 35.86% to Rs 174.71 crore in the year ended March 2026 as against Rs 272.40 crore during the previous year ended March 2025. Sales declined 13.98% to Rs 1819.44 crore in the year ended March 2026 as against Rs 2115.07 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales582.64563.78 3 1819.442115.07 -14
OPM %19.4225.83 -20.2921.96 -
PBDT109.83137.44 -20 340.05447.59 -24
PBT81.68114.62 -29 235.71360.69 -35
NP61.1288.34 -31 174.71272.40 -36

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)